vs

Side-by-side financial comparison of MIMEDX GROUP, INC. (MDXG) and SunPower Inc. (SPWR). Click either name above to swap in a different company.

MIMEDX GROUP, INC. is the larger business by last-quarter revenue ($118.1M vs $79.7M, roughly 1.5× SunPower Inc.). MIMEDX GROUP, INC. runs the higher net margin — 12.9% vs -17.8%, a 30.6% gap on every dollar of revenue. On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs -10.1%). Over the past eight quarters, SunPower Inc.'s revenue compounded faster (118.7% CAGR vs 18.1%).

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

SunPower Corporation is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company, headquartered in San Jose, California, was founded in 1985 by Richard Swanson, an electrical engineering professor from Stanford University. Cypress Semiconductor bought a majority interest in the company in 2002, growing it quickly until SunPower went public in 2005. TotalEnergies, a French energy and oil company p...

MDXG vs SPWR — Head-to-Head

Bigger by revenue
MDXG
MDXG
1.5× larger
MDXG
$118.1M
$79.7M
SPWR
Growing faster (revenue YoY)
MDXG
MDXG
+37.2% gap
MDXG
27.1%
-10.1%
SPWR
Higher net margin
MDXG
MDXG
30.6% more per $
MDXG
12.9%
-17.8%
SPWR
Faster 2-yr revenue CAGR
SPWR
SPWR
Annualised
SPWR
118.7%
18.1%
MDXG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDXG
MDXG
SPWR
SPWR
Revenue
$118.1M
$79.7M
Net Profit
$15.2M
$-14.2M
Gross Margin
83.9%
35.5%
Operating Margin
17.8%
-27.4%
Net Margin
12.9%
-17.8%
Revenue YoY
27.1%
-10.1%
Net Profit YoY
104.2%
-130.1%
EPS (diluted)
$0.10
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDXG
MDXG
SPWR
SPWR
Q4 25
$118.1M
$79.7M
Q3 25
$113.7M
$22.0M
Q2 25
$98.6M
$67.5M
Q1 25
$88.2M
$82.7M
Q4 24
$92.9M
$88.7M
Q3 24
$84.1M
Q2 24
$87.2M
Q1 24
$84.7M
Net Profit
MDXG
MDXG
SPWR
SPWR
Q4 25
$15.2M
$-14.2M
Q3 25
$16.7M
$-16.9M
Q2 25
$9.6M
$-22.4M
Q1 25
$7.0M
$8.1M
Q4 24
$7.4M
$47.0M
Q3 24
$8.1M
Q2 24
$17.6M
Q1 24
$9.3M
Gross Margin
MDXG
MDXG
SPWR
SPWR
Q4 25
83.9%
35.5%
Q3 25
83.5%
Q2 25
81.1%
42.6%
Q1 25
81.2%
48.5%
Q4 24
81.8%
46.5%
Q3 24
81.8%
Q2 24
83.0%
Q1 24
84.7%
Operating Margin
MDXG
MDXG
SPWR
SPWR
Q4 25
17.8%
-27.4%
Q3 25
19.5%
-15.7%
Q2 25
12.5%
-4.0%
Q1 25
9.4%
1.3%
Q4 24
11.9%
-24.2%
Q3 24
13.3%
Q2 24
26.9%
Q1 24
15.6%
Net Margin
MDXG
MDXG
SPWR
SPWR
Q4 25
12.9%
-17.8%
Q3 25
14.7%
-76.9%
Q2 25
9.8%
-33.2%
Q1 25
8.0%
9.8%
Q4 24
8.0%
53.0%
Q3 24
9.6%
Q2 24
20.2%
Q1 24
10.9%
EPS (diluted)
MDXG
MDXG
SPWR
SPWR
Q4 25
$0.10
$-0.05
Q3 25
$0.11
$-0.19
Q2 25
$0.06
$-0.28
Q1 25
$0.05
$0.00
Q4 24
$0.05
$0.27
Q3 24
$0.05
Q2 24
$0.12
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDXG
MDXG
SPWR
SPWR
Cash + ST InvestmentsLiquidity on hand
$166.1M
$9.6M
Total DebtLower is stronger
$18.0M
$164.8M
Stockholders' EquityBook value
$256.5M
$-90.1M
Total Assets
$342.7M
$241.2M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDXG
MDXG
SPWR
SPWR
Q4 25
$166.1M
$9.6M
Q3 25
$142.1M
$5.1M
Q2 25
$118.9M
$11.1M
Q1 25
$106.4M
$10.6M
Q4 24
$104.4M
$13.4M
Q3 24
$88.8M
Q2 24
$69.0M
Q1 24
$48.5M
Total Debt
MDXG
MDXG
SPWR
SPWR
Q4 25
$18.0M
$164.8M
Q3 25
$204.3M
Q2 25
$152.9M
Q1 25
Q4 24
$19.0M
$147.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MDXG
MDXG
SPWR
SPWR
Q4 25
$256.5M
$-90.1M
Q3 25
$238.9M
$-112.3M
Q2 25
$216.6M
$-107.2M
Q1 25
$202.8M
$-89.0M
Q4 24
$193.1M
$-97.5M
Q3 24
$181.0M
Q2 24
$168.0M
Q1 24
$155.7M
Total Assets
MDXG
MDXG
SPWR
SPWR
Q4 25
$342.7M
$241.2M
Q3 25
$319.0M
$208.3M
Q2 25
$291.1M
$163.1M
Q1 25
$270.4M
$147.8M
Q4 24
$263.9M
$144.5M
Q3 24
$243.9M
Q2 24
$230.2M
Q1 24
$221.7M
Debt / Equity
MDXG
MDXG
SPWR
SPWR
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDXG
MDXG
SPWR
SPWR
Operating Cash FlowLast quarter
$25.0M
$-1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDXG
MDXG
SPWR
SPWR
Q4 25
$25.0M
$-1.9M
Q3 25
$29.3M
$-6.4M
Q2 25
$14.4M
$-4.4M
Q1 25
$5.3M
$-2.6M
Q4 24
$18.8M
$-25.6M
Q3 24
$19.6M
Q2 24
$21.8M
Q1 24
$6.0M
Cash Conversion
MDXG
MDXG
SPWR
SPWR
Q4 25
1.64×
Q3 25
1.75×
Q2 25
1.50×
Q1 25
0.75×
-0.32×
Q4 24
2.53×
-0.54×
Q3 24
2.42×
Q2 24
1.24×
Q1 24
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

SPWR
SPWR

Residential Solar Installation$46.9M59%
New Homes Business$22.7M29%
Other$10.1M13%

Related Comparisons